AnalystsLaura PrendergastLaura Prendergast's Stock Forecasts
AnalystsLaura Prendergast
Sectors:
Industries:
Analyst Ranking
Bottom 14%
#4473 out of 5158 analysts
Average Return
-3.1%
Win Rate
40%6 out of 15
Risk vs Reward
Poor
Good
Laura Prendergast's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Erasca IncERAS | +129.05% | $1.48 | $3.39 | 2025-03-26 - 2025-12-23 | Buy |
Revolution Medicines IncRVMD | +61.57% | $49.68 | $80.27 | 2025-10-16 - 2025-12-23 | Strong Buy |
Revolution Medicines IncRVMD | +45.95% | $27.38 | $39.96 | 2024-01-16 - 2025-01-15 | Buy |
Erasca IncERAS | +33.99% | $2.53 | $3.39 | 2025-10-16 - 2025-12-23 | Strong Buy |
Foghorn Therapeutics IncFHTX | +21.18% | $4.58 | $5.55 | 2025-12-04 - 2025-12-23 | Strong Buy |
Laura Prendergast Analyst Color
Get additional color on Laura Prendergast's coverage of popular stocks
Laura Prendergast's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | 1 | Strong Buy | $15.00 | +75.85% | Initiates Coverage On | 20 days ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $12.00 | +116.22% | Initiates Coverage On | 20 days ago |
Nuvalent IncNUVL | 2 | Strong Buy | $135.00 | +28.78% | Maintains | a month ago |
Black Diamond Therapeutics IncBDTX | 2 | Strong Buy | $8.00 | +213.73% | Reinstates | 2 months ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $85.00 | +5.89% | Reinstates | 2 months ago |
Erasca IncERAS | 2 | Strong Buy | $4.00 | +17.99% | Initiates Coverage On | 2 months ago |
Cogent Biosciences IncCOGT | 1 | Hold | $16.00 | -60.17% | Initiates Coverage On | 2 months ago |
Mural Oncology PLCMURA | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Nkarta IncNKTX | 2 | Strong Buy | $16.00 | N/A | Upgrades | a year ago |
Third Harmonic Bio IncTHRD | 1 | Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.